Openlandscape
Drug pipelines, clinical trials and upcoming readouts for any disease, target or company, with every fact linked to its source.
- Brand
- OpenLandscape
- Category
- Data & Analytics
- Primary Subcategory
- Biomedical & Pharma Research Intelligence
Integration details
Description
OpenLandscape tracks the drugs in clinical development, built from ClinicalTrials.gov, openFDA and company filings. Each drug's names are merged across codes and brands (mazdutide = LY3305677 = IBI362), so one question finds it under any name. Ask in plain words: - "Map every amylin drug in Phase 2 or later, with next milestones." - "Tell me everything about mazdutide." - "Which oral GLP-1s read out in the next six months?" - "List Phase 3 obesity trials running in China." - "Who runs the most Phase 3 lung cancer trials in China?" - "What changed in what I follow this week?" Every answer is a table in which each phase, date and number links to its source (the trial registry record, the FDA label or the press report), so you can check it before you use it. Facts from press reports are marked "news". The data is updated every weekday. What it can do: landscapes of every drug in a disease, target, mechanism or company; one drug in full (names, company, stage, approvals, upcoming dates, trials); trials by drug, company, phase, country or date; upcoming readouts and regulator decisions; the companies and hospitals running the most trials; and what changed in the landscapes, drugs and companies you follow. All tools only read. Nothing in your account can be changed through Claude. A free OpenLandscape account (email or Google, no card) includes 25 questions a month, the top 10 of each list and one landscape in full. Solo ($49 a month, excl. VAT) opens every list, follows 5 landscapes, drugs or companies, and shows every change.
- Integration type
- Connector
- Verification status
Community connector- Platform
- Claude
- Primary Subcategory
- Biomedical & Pharma Research Intelligence
- Secondary Subcategories
- None listed
- Brand
- OpenLandscape
- Access
- Account required
- First tracked
- 2026-11-15
- Tool count
- 8
- Market
- US
The Primary Subcategory used for this profile’s headline score.
Other Subcategories where the Integration is listed.
Claude Connector discovery is coming soon
Community Connectors only appear in Claude’s registry.Once verified, organic discovery begins and we can calculate your score.Read more about Community Connector verification.
No spam. Unsubscribe any time.
What discovery looks like

Claude can surface verified Connectors when they match a user’s Prompt.
How Claude Connector discovery works
Your Connector will compete to appear for users’ Prompts once Claude verifies it
Competing in Claude Biomedical & Pharma Research Intelligence
View Category8 tools agents can invoke
Openlandscape Claude Connector FAQ
How the directory, categories and Discoverability Score work.
Read the methodologyHow do I improve Openlandscape's Claude Connector discoverability?
The levers are the listing surface agents actually read: names, descriptions, keywords, tool metadata, and registry health. Which lever matters depends on where discovery breaks, which is what continuous measurement shows.
What are Openlandscape alternatives on Claude?
As of 2026-11-16, Openlandscape competes with Clinical Trials, AdisInsight, AgingResearch.News, Amass Connector, Boltz API, BPIQ, Convoke, Cortellis CMC Intelligence and 27 more in Claude Biomedical & Pharma Research Intelligence, ranked by public Discoverability Score.
Where is this profile measured?
This profile uses the geography attached to the latest public registry snapshot: US. Locale tags are intentionally omitted.


